TNGXTango Therapeutics Inc.

23.88USD-5.24%Mkt Cap: 4.03B $P/E:

Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative prot…

Key Statistics

Company
Market Cap4.03B $
Enterprise Value2.98B $
Revenue (TTM)53.81M $
Gross Profit-79.84M $
Net Income (TTM)-101.59M $
Revenue/Share0.3980 USD
Last Price23.88 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees137
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-14.44
PEG
EV/EBITDA-22.18
EV/Revenue55.42
P/S73.67
P/B8.66
EPS (TTM)-0.78
EPS (Forward)-1.63
52W Range
6.25063% of range34.39
52W High34.39 USD
52W Low6.250 USD
Profitability
Gross Margin-148.37%
Oper. Margin-253.38%
EBITDA Margin-249.81%
Profit Margin-162.85%
ROE-29.35%
ROA-25.48%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-138.89M $
CapEx (TTM)1.05M $
FCF Margin-133.57%
FCF Yield-1.79%
Net Debt-982.00M $
Net Debt/EBITDA7.31
Balance Sheet
Debt/Equity0.10
Current Ratio50.82
Quick Ratio49.95
Book Value/Sh2.716 USD
Cash/Share6.014 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)44.75 USD
Upside (mean)+87.4%
Target Range24.00 USD69.00 USD
$24.00+87.4% to mean$69.00
# Analysts12
Ownership
Shares Out.168.61M
Float120.34M
Insiders1.13%
Institutions129.03%
Short Interest
Short Ratio16.7d
Short % Float26.79%
Short % Out.26.49%
Shares Short44.61M
Short (prev mo.)42.01M
Technical
SMA 5028.51 (-16.2%)
SMA 20018.73 (+27.5%)
Beta1.15
S&P 52W Chg18.16%
Avg Vol (30d)2.11M
Avg Vol (10d)2.25M
Technical Indicators
RSI (14)35.7
MACD-0.8624
MACD Signal-0.5316
MACD Hist.-0.3309
BB Upper29.50 USD
BB Middle26.73 USD
BB Lower23.97 USD
BB Width20.66%
ATR (14)1.593 USD
Vol Ratio (20d)1.28x